Beta-blockers revisited: picking patients with alcoholic cirrhosis who will benefit.
Bay
M K
MK
Department of Medicine, University of Texas Health Science Center, San Antonio, USA.
Schenker
S
S
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000534:rehabilitation*; D018579:Patient Selection; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists